| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Floor | 8 | 2021 | 138 | 2.510 |
Why?
|
| Uterine Prolapse | 23 | 2008 | 68 | 2.440 |
Why?
|
| Tuberculosis, Meningeal | 11 | 2021 | 47 | 1.450 |
Why?
|
| Gynecologic Surgical Procedures | 14 | 2020 | 284 | 1.320 |
Why?
|
| Urinary Incontinence, Stress | 16 | 2009 | 174 | 1.240 |
Why?
|
| Urinary Incontinence | 9 | 2018 | 489 | 1.140 |
Why?
|
| Aneurysm, False | 3 | 2018 | 255 | 0.900 |
Why?
|
| Pelvic Organ Prolapse | 6 | 2020 | 112 | 0.900 |
Why?
|
| Surgical Mesh | 5 | 2012 | 311 | 0.780 |
Why?
|
| Rectocele | 8 | 2008 | 21 | 0.760 |
Why?
|
| Urogenital Surgical Procedures | 7 | 2007 | 33 | 0.710 |
Why?
|
| Exercise Therapy | 2 | 2018 | 929 | 0.710 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 2018 | 19 | 0.620 |
Why?
|
| Blood Preservation | 1 | 2018 | 169 | 0.590 |
Why?
|
| Conversion Disorder | 1 | 2021 | 202 | 0.590 |
Why?
|
| Leprosy, Borderline | 1 | 2016 | 4 | 0.560 |
Why?
|
| Fecal Incontinence | 2 | 2018 | 242 | 0.560 |
Why?
|
| Vagina | 11 | 2016 | 841 | 0.560 |
Why?
|
| Laparoscopy | 11 | 2020 | 2030 | 0.540 |
Why?
|
| Single-Chain Antibodies | 4 | 2022 | 111 | 0.530 |
Why?
|
| Obstetric Labor Complications | 1 | 2018 | 236 | 0.530 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 474 | 0.530 |
Why?
|
| Hypersplenism | 1 | 2015 | 4 | 0.510 |
Why?
|
| Abscess | 2 | 2016 | 606 | 0.500 |
Why?
|
| Hysterectomy, Vaginal | 2 | 2005 | 28 | 0.490 |
Why?
|
| Splenic Artery | 1 | 2015 | 57 | 0.480 |
Why?
|
| Postpartum Hemorrhage | 1 | 2018 | 272 | 0.480 |
Why?
|
| Skin Transplantation | 4 | 2008 | 1083 | 0.460 |
Why?
|
| Lipid Bilayers | 2 | 2006 | 383 | 0.460 |
Why?
|
| Microarray Analysis | 2 | 2007 | 748 | 0.450 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 568 | 0.440 |
Why?
|
| LEOPARD Syndrome | 1 | 2013 | 12 | 0.430 |
Why?
|
| Urinary Bladder Diseases | 5 | 2006 | 167 | 0.420 |
Why?
|
| Blood Transfusion | 2 | 2018 | 1299 | 0.420 |
Why?
|
| Antibodies | 2 | 2020 | 2414 | 0.410 |
Why?
|
| Rectovaginal Fistula | 2 | 2004 | 12 | 0.410 |
Why?
|
| Antibodies, Bispecific | 4 | 2019 | 196 | 0.390 |
Why?
|
| Subacute Sclerosing Panencephalitis | 1 | 2011 | 26 | 0.380 |
Why?
|
| Receptor, erbB-3 | 4 | 2013 | 143 | 0.370 |
Why?
|
| Nanostructures | 2 | 2007 | 551 | 0.370 |
Why?
|
| Polymers | 3 | 2007 | 1614 | 0.370 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 261 | 0.370 |
Why?
|
| Medical Receptionists | 1 | 2010 | 2 | 0.360 |
Why?
|
| Antibodies, Monoclonal | 8 | 2019 | 9172 | 0.360 |
Why?
|
| Stomach Volvulus | 1 | 2010 | 6 | 0.360 |
Why?
|
| Diaphragmatic Eventration | 1 | 2010 | 4 | 0.360 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2022 | 130 | 0.350 |
Why?
|
| Biosensing Techniques | 3 | 2007 | 647 | 0.350 |
Why?
|
| Aneurysm, Ruptured | 1 | 2015 | 464 | 0.340 |
Why?
|
| Marketing of Health Services | 1 | 2010 | 150 | 0.330 |
Why?
|
| Immunoconjugates | 3 | 2024 | 951 | 0.320 |
Why?
|
| Embolization, Therapeutic | 2 | 2018 | 1418 | 0.320 |
Why?
|
| Tic Disorders | 1 | 2010 | 136 | 0.320 |
Why?
|
| Prosthesis Implantation | 2 | 2012 | 591 | 0.320 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2010 | 113 | 0.310 |
Why?
|
| Practice Management, Medical | 1 | 2010 | 191 | 0.310 |
Why?
|
| Enzymes, Immobilized | 2 | 2007 | 52 | 0.310 |
Why?
|
| Dendrimers | 2 | 2007 | 72 | 0.310 |
Why?
|
| Trigeminal Nerve | 1 | 2010 | 248 | 0.300 |
Why?
|
| Nylons | 1 | 2007 | 46 | 0.290 |
Why?
|
| Community-Acquired Infections | 2 | 2022 | 469 | 0.290 |
Why?
|
| Facial Nerve | 1 | 2010 | 277 | 0.290 |
Why?
|
| Urodynamics | 6 | 2009 | 344 | 0.280 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2007 | 98 | 0.280 |
Why?
|
| Nanocomposites | 1 | 2007 | 49 | 0.280 |
Why?
|
| Telephone | 1 | 2010 | 626 | 0.270 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2024 | 3599 | 0.270 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2007 | 142 | 0.270 |
Why?
|
| Nanoparticles | 4 | 2022 | 1957 | 0.270 |
Why?
|
| Albendazole | 3 | 2020 | 50 | 0.270 |
Why?
|
| Gold | 2 | 2007 | 481 | 0.260 |
Why?
|
| Electronics | 2 | 2007 | 316 | 0.260 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 1662 | 0.260 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2018 | 198 | 0.260 |
Why?
|
| India | 10 | 2021 | 2286 | 0.260 |
Why?
|
| Brain Stem | 1 | 2011 | 858 | 0.250 |
Why?
|
| Sutures | 2 | 1998 | 282 | 0.250 |
Why?
|
| Electrolytes | 1 | 2006 | 274 | 0.250 |
Why?
|
| Vaginal Diseases | 3 | 2002 | 103 | 0.250 |
Why?
|
| Aorta | 1 | 2013 | 2041 | 0.240 |
Why?
|
| Neurocysticercosis | 2 | 2020 | 91 | 0.240 |
Why?
|
| Humans | 116 | 2024 | 760617 | 0.230 |
Why?
|
| Maleimides | 1 | 2024 | 112 | 0.230 |
Why?
|
| Liposomes | 2 | 2019 | 784 | 0.230 |
Why?
|
| Urination Disorders | 2 | 2002 | 238 | 0.230 |
Why?
|
| Hysteroscopy | 1 | 2004 | 62 | 0.230 |
Why?
|
| Female | 90 | 2024 | 392148 | 0.230 |
Why?
|
| Tuberculoma | 5 | 2016 | 13 | 0.220 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15828 | 0.210 |
Why?
|
| Radiography, Thoracic | 3 | 2018 | 1302 | 0.210 |
Why?
|
| Phospholipids | 1 | 2006 | 786 | 0.210 |
Why?
|
| BCG Vaccine | 1 | 2005 | 369 | 0.210 |
Why?
|
| Membranes | 1 | 2022 | 165 | 0.210 |
Why?
|
| Electromyography | 2 | 2018 | 1393 | 0.200 |
Why?
|
| Adsorption | 2 | 2017 | 197 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 36402 | 0.200 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2017 | 1540 | 0.200 |
Why?
|
| Receptor, EphA2 | 2 | 2019 | 41 | 0.200 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 1333 | 0.200 |
Why?
|
| Spinal Nerve Roots | 1 | 2002 | 121 | 0.190 |
Why?
|
| Amnion | 1 | 2022 | 197 | 0.190 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2018 | 1431 | 0.190 |
Why?
|
| Durapatite | 1 | 2022 | 163 | 0.190 |
Why?
|
| Pelvis | 2 | 2003 | 732 | 0.190 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2013 | 380 | 0.180 |
Why?
|
| Tissue Transplantation | 1 | 2001 | 128 | 0.180 |
Why?
|
| Protein Engineering | 3 | 2016 | 548 | 0.180 |
Why?
|
| Hematoma | 1 | 2005 | 762 | 0.180 |
Why?
|
| Cysticercus | 1 | 2020 | 2 | 0.180 |
Why?
|
| Cicatrix | 2 | 2022 | 785 | 0.180 |
Why?
|
| Heart Ventricles | 1 | 2013 | 3796 | 0.180 |
Why?
|
| Anthelmintics | 2 | 2020 | 83 | 0.170 |
Why?
|
| Treatment Outcome | 22 | 2020 | 64568 | 0.170 |
Why?
|
| Pelvic Pain | 1 | 2021 | 292 | 0.160 |
Why?
|
| Oligopeptides | 1 | 2024 | 1185 | 0.160 |
Why?
|
| Hospitals, University | 2 | 2014 | 564 | 0.160 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 1998 | 27 | 0.160 |
Why?
|
| Hematocrit | 1 | 2000 | 623 | 0.160 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2018 | 55 | 0.150 |
Why?
|
| Enbucrilate | 1 | 2018 | 30 | 0.150 |
Why?
|
| Protein Stability | 2 | 2017 | 578 | 0.150 |
Why?
|
| Pneumococcal Infections | 1 | 2022 | 501 | 0.150 |
Why?
|
| Suture Techniques | 4 | 2012 | 768 | 0.150 |
Why?
|
| Hydrocephalus | 2 | 2016 | 764 | 0.150 |
Why?
|
| Antitubercular Agents | 4 | 2020 | 1374 | 0.150 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2019 | 271 | 0.140 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 344 | 0.140 |
Why?
|
| Prospective Studies | 18 | 2022 | 54360 | 0.140 |
Why?
|
| Ephrin-A2 | 1 | 2016 | 25 | 0.140 |
Why?
|
| Phlebography | 1 | 2018 | 326 | 0.140 |
Why?
|
| Pneumonia | 2 | 2020 | 2143 | 0.140 |
Why?
|
| Cerebral Veins | 1 | 2018 | 157 | 0.140 |
Why?
|
| Parenting | 1 | 2023 | 702 | 0.140 |
Why?
|
| Eclampsia | 1 | 2017 | 56 | 0.140 |
Why?
|
| Arachnoiditis | 1 | 2016 | 9 | 0.140 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2017 | 49 | 0.140 |
Why?
|
| Abnormalities, Multiple | 2 | 2012 | 1422 | 0.140 |
Why?
|
| Renal Artery | 1 | 2018 | 351 | 0.130 |
Why?
|
| Chromatography, Gel | 1 | 2017 | 645 | 0.130 |
Why?
|
| Osteosclerosis | 1 | 1996 | 42 | 0.130 |
Why?
|
| Endometritis | 1 | 1996 | 49 | 0.130 |
Why?
|
| Electric Stimulation Therapy | 1 | 2002 | 626 | 0.130 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 745 | 0.130 |
Why?
|
| Biofeedback, Psychology | 1 | 2016 | 116 | 0.130 |
Why?
|
| Cyanosis | 2 | 2013 | 82 | 0.130 |
Why?
|
| Middle Aged | 46 | 2021 | 220584 | 0.130 |
Why?
|
| Copper | 1 | 2018 | 367 | 0.130 |
Why?
|
| Thorax | 1 | 2018 | 555 | 0.130 |
Why?
|
| Hemostatics | 1 | 2018 | 240 | 0.120 |
Why?
|
| Adult | 39 | 2021 | 220969 | 0.120 |
Why?
|
| Bone Diseases, Developmental | 1 | 1996 | 131 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2002 | 1269 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2019 | 571 | 0.120 |
Why?
|
| Child, Preschool | 14 | 2021 | 42188 | 0.120 |
Why?
|
| Infant | 12 | 2021 | 36152 | 0.120 |
Why?
|
| Antibody Specificity | 1 | 2017 | 1058 | 0.120 |
Why?
|
| Pain | 1 | 2010 | 5061 | 0.120 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2016 | 266 | 0.120 |
Why?
|
| Mice, SCID | 5 | 2020 | 2625 | 0.120 |
Why?
|
| Drug Delivery Systems | 2 | 2016 | 2222 | 0.120 |
Why?
|
| Male | 35 | 2021 | 360358 | 0.120 |
Why?
|
| Cytotoxins | 1 | 2015 | 153 | 0.110 |
Why?
|
| Surgical Flaps | 1 | 2003 | 1670 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1226 | 0.110 |
Why?
|
| Leprosy, Tuberculoid | 1 | 2013 | 15 | 0.110 |
Why?
|
| Neuritis | 1 | 2013 | 35 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2018 | 20556 | 0.110 |
Why?
|
| Software | 2 | 2018 | 4431 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1835 | 0.110 |
Why?
|
| Vaccination | 1 | 2005 | 3370 | 0.110 |
Why?
|
| Adolescent | 22 | 2021 | 88234 | 0.110 |
Why?
|
| Surgery Department, Hospital | 1 | 2014 | 176 | 0.110 |
Why?
|
| Leprosy | 1 | 2013 | 126 | 0.110 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 2008 | 0.100 |
Why?
|
| Spinal Diseases | 1 | 2017 | 561 | 0.100 |
Why?
|
| Urologic Surgical Procedures | 2 | 2009 | 296 | 0.100 |
Why?
|
| Vascular Fistula | 1 | 2012 | 50 | 0.100 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2018 | 831 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 2495 | 0.100 |
Why?
|
| Suburethral Slings | 1 | 2012 | 66 | 0.100 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2013 | 164 | 0.100 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2011 | 20 | 0.100 |
Why?
|
| Syndrome | 2 | 2015 | 3268 | 0.090 |
Why?
|
| World Health Organization | 1 | 2017 | 1321 | 0.090 |
Why?
|
| Cell Line, Tumor | 8 | 2024 | 16967 | 0.090 |
Why?
|
| Health Literacy | 1 | 2016 | 443 | 0.090 |
Why?
|
| Neuregulin-1 | 1 | 2012 | 135 | 0.090 |
Why?
|
| Oral Health | 1 | 2016 | 492 | 0.090 |
Why?
|
| Pineal Gland | 1 | 1992 | 158 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2021 | 3546 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2017 | 703 | 0.090 |
Why?
|
| Aged | 30 | 2021 | 169042 | 0.090 |
Why?
|
| Device Approval | 1 | 2012 | 163 | 0.090 |
Why?
|
| Child | 20 | 2023 | 80079 | 0.090 |
Why?
|
| Anticestodal Agents | 1 | 2010 | 3 | 0.090 |
Why?
|
| Drug Design | 2 | 2013 | 1045 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 6520 | 0.090 |
Why?
|
| Situs Inversus | 1 | 2010 | 63 | 0.090 |
Why?
|
| Patient Satisfaction | 3 | 2016 | 3451 | 0.090 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 808 | 0.090 |
Why?
|
| Home Care Services | 1 | 2016 | 648 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 1265 | 0.090 |
Why?
|
| Vaccines, Conjugate | 2 | 2022 | 328 | 0.080 |
Why?
|
| Proteins | 1 | 2004 | 6030 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2007 | 2639 | 0.080 |
Why?
|
| Ligaments | 3 | 2005 | 127 | 0.080 |
Why?
|
| Parents | 1 | 2023 | 3563 | 0.080 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2012 | 339 | 0.080 |
Why?
|
| Urinary Tract | 3 | 2001 | 313 | 0.080 |
Why?
|
| Hysterectomy | 3 | 2000 | 856 | 0.080 |
Why?
|
| Equipment Design | 1 | 2016 | 3501 | 0.080 |
Why?
|
| Vestibular Diseases | 1 | 2011 | 231 | 0.080 |
Why?
|
| Colpotomy | 1 | 2008 | 9 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 3680 | 0.070 |
Why?
|
| Pancreatitis | 1 | 2015 | 1097 | 0.070 |
Why?
|
| Granuloma | 1 | 2010 | 328 | 0.070 |
Why?
|
| Thermoanaerobacter | 1 | 2007 | 1 | 0.070 |
Why?
|
| L-Iditol 2-Dehydrogenase | 1 | 2007 | 3 | 0.070 |
Why?
|
| Inservice Training | 1 | 2010 | 375 | 0.070 |
Why?
|
| Valerates | 1 | 2007 | 20 | 0.070 |
Why?
|
| Butyrylcholinesterase | 1 | 2007 | 21 | 0.070 |
Why?
|
| Conductometry | 1 | 2007 | 10 | 0.070 |
Why?
|
| Robotics | 1 | 2014 | 816 | 0.070 |
Why?
|
| Phenylacetates | 1 | 2007 | 112 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 3730 | 0.070 |
Why?
|
| Tuberculosis | 1 | 2020 | 2015 | 0.070 |
Why?
|
| Acetylcholinesterase | 1 | 2007 | 156 | 0.070 |
Why?
|
| Psychometrics | 1 | 2016 | 3060 | 0.070 |
Why?
|
| Cystocele | 1 | 2006 | 4 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2013 | 2864 | 0.070 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2007 | 111 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2019 | 10432 | 0.070 |
Why?
|
| Electrochemistry | 1 | 2006 | 145 | 0.070 |
Why?
|
| Colloids | 1 | 2006 | 123 | 0.070 |
Why?
|
| Quartz | 1 | 2006 | 23 | 0.070 |
Why?
|
| Polyamines | 1 | 2007 | 133 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2019 | 1827 | 0.070 |
Why?
|
| Diagnosis, Differential | 5 | 2017 | 12966 | 0.070 |
Why?
|
| Pneumococcal Vaccines | 2 | 2022 | 397 | 0.070 |
Why?
|
| Angiography | 1 | 2012 | 1596 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 2016 | 1310 | 0.070 |
Why?
|
| Appointments and Schedules | 1 | 2010 | 442 | 0.070 |
Why?
|
| Prosthesis Failure | 1 | 2011 | 1204 | 0.070 |
Why?
|
| Antigens | 1 | 2012 | 1441 | 0.070 |
Why?
|
| Models, Structural | 1 | 2006 | 340 | 0.070 |
Why?
|
| Solutions | 1 | 2006 | 412 | 0.070 |
Why?
|
| Postoperative Complications | 8 | 2020 | 15612 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2021 | 41457 | 0.060 |
Why?
|
| Follow-Up Studies | 10 | 2020 | 39063 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4571 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2789 | 0.060 |
Why?
|
| Pyrazinamide | 1 | 2005 | 60 | 0.060 |
Why?
|
| Young Adult | 11 | 2021 | 59179 | 0.060 |
Why?
|
| Signal Transduction | 4 | 2019 | 23416 | 0.060 |
Why?
|
| Anemia | 1 | 2015 | 1504 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2006 | 544 | 0.060 |
Why?
|
| Private Practice | 1 | 2006 | 153 | 0.060 |
Why?
|
| Heart Atria | 1 | 2011 | 1333 | 0.060 |
Why?
|
| Microchemistry | 1 | 2004 | 54 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 6483 | 0.060 |
Why?
|
| Electrodes | 1 | 2007 | 610 | 0.060 |
Why?
|
| Dyspnea | 1 | 2013 | 1347 | 0.060 |
Why?
|
| Hernia | 2 | 2002 | 68 | 0.060 |
Why?
|
| Catalytic Domain | 1 | 2007 | 704 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 944 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 3356 | 0.060 |
Why?
|
| Respiration | 1 | 2011 | 1656 | 0.060 |
Why?
|
| Acute Disease | 1 | 2015 | 7237 | 0.060 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 555 | 0.060 |
Why?
|
| Alcoholism | 1 | 2015 | 1972 | 0.060 |
Why?
|
| Animals | 15 | 2024 | 168201 | 0.060 |
Why?
|
| Isoniazid | 1 | 2005 | 283 | 0.060 |
Why?
|
| Pregnancy | 5 | 2018 | 29868 | 0.060 |
Why?
|
| Social Behavior | 1 | 2010 | 1135 | 0.060 |
Why?
|
| Neoplasms | 5 | 2020 | 22131 | 0.050 |
Why?
|
| Rifampin | 1 | 2005 | 339 | 0.050 |
Why?
|
| Warfarin | 1 | 2012 | 1477 | 0.050 |
Why?
|
| Calcinosis | 1 | 1992 | 1469 | 0.050 |
Why?
|
| Transplantation, Homologous | 3 | 2002 | 4804 | 0.050 |
Why?
|
| Taxoids | 2 | 2019 | 667 | 0.050 |
Why?
|
| Child Rearing | 1 | 2023 | 73 | 0.050 |
Why?
|
| Retrospective Studies | 15 | 2020 | 80566 | 0.050 |
Why?
|
| Valine | 1 | 2024 | 408 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 1924 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2024 | 901 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 2802 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2004 | 281 | 0.050 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 14648 | 0.050 |
Why?
|
| Fluorescence | 1 | 2004 | 756 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2015 | 5034 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2006 | 1878 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 1509 | 0.050 |
Why?
|
| Surface Properties | 1 | 2004 | 1161 | 0.050 |
Why?
|
| Dyspareunia | 1 | 2002 | 47 | 0.050 |
Why?
|
| Vasospasm, Intracranial | 1 | 2004 | 214 | 0.050 |
Why?
|
| Receptor, erbB-2 | 1 | 2012 | 2553 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5863 | 0.050 |
Why?
|
| Organ Preservation | 1 | 2004 | 382 | 0.050 |
Why?
|
| Urination | 1 | 2002 | 201 | 0.040 |
Why?
|
| Cell Line | 1 | 2015 | 15576 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2019 | 1892 | 0.040 |
Why?
|
| Transplantation, Heterologous | 2 | 2009 | 2382 | 0.040 |
Why?
|
| Dermis | 1 | 2002 | 202 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7389 | 0.040 |
Why?
|
| Uterus | 1 | 2004 | 649 | 0.040 |
Why?
|
| Prolapse | 1 | 2000 | 63 | 0.040 |
Why?
|
| Sacrum | 1 | 2002 | 274 | 0.040 |
Why?
|
| Genital Diseases, Female | 1 | 2001 | 192 | 0.040 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2022 | 445 | 0.040 |
Why?
|
| Incidence | 6 | 2016 | 21337 | 0.040 |
Why?
|
| Digoxin | 1 | 1981 | 246 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2005 | 1113 | 0.040 |
Why?
|
| Disulfides | 1 | 2022 | 464 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2010 | 2768 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2013 | 5964 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2012 | 2778 | 0.040 |
Why?
|
| Meningoencephalitis | 1 | 1999 | 83 | 0.040 |
Why?
|
| Mice | 7 | 2024 | 81368 | 0.040 |
Why?
|
| Seizures | 3 | 2020 | 2954 | 0.040 |
Why?
|
| Abdomen | 2 | 2009 | 1128 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2020 | 816 | 0.040 |
Why?
|
| Echinococcosis, Pulmonary | 1 | 1998 | 7 | 0.040 |
Why?
|
| Aged, 80 and over | 11 | 2018 | 58894 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 3527 | 0.040 |
Why?
|
| Postoperative Period | 2 | 2001 | 1813 | 0.040 |
Why?
|
| Recurrence | 6 | 2002 | 8426 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2023 | 761 | 0.040 |
Why?
|
| Wounds, Penetrating | 1 | 2000 | 313 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2012 | 6233 | 0.040 |
Why?
|
| Developing Countries | 1 | 2010 | 2867 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13635 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 2315 | 0.040 |
Why?
|
| Fundus Oculi | 1 | 1999 | 556 | 0.040 |
Why?
|
| Materials Testing | 1 | 2001 | 862 | 0.040 |
Why?
|
| Brain Diseases | 3 | 1992 | 1545 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2002 | 838 | 0.040 |
Why?
|
| Videotape Recording | 1 | 1998 | 338 | 0.040 |
Why?
|
| Thoracic Diseases | 1 | 1998 | 99 | 0.040 |
Why?
|
| Epitopes | 2 | 2015 | 2501 | 0.030 |
Why?
|
| Rectum | 1 | 2002 | 891 | 0.030 |
Why?
|
| Cystoscopy | 1 | 1997 | 130 | 0.030 |
Why?
|
| Pelvic Bones | 1 | 1999 | 270 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2002 | 571 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2006 | 5433 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2012 | 4785 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2013 | 3605 | 0.030 |
Why?
|
| Minnesota | 1 | 2016 | 338 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2004 | 1033 | 0.030 |
Why?
|
| Suppuration | 1 | 1996 | 60 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2020 | 706 | 0.030 |
Why?
|
| Anticonvulsants | 2 | 2020 | 1906 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 1999 | 300 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 6305 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2016 | 419 | 0.030 |
Why?
|
| Optic Atrophy | 1 | 1996 | 79 | 0.030 |
Why?
|
| Ligands | 2 | 2015 | 3268 | 0.030 |
Why?
|
| Decision Trees | 1 | 2017 | 504 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1997 | 350 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2011 | 6237 | 0.030 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 1996 | 72 | 0.030 |
Why?
|
| Epilepsy, Generalized | 1 | 1997 | 178 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2261 | 0.030 |
Why?
|
| Intraoperative Complications | 2 | 2003 | 1161 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5110 | 0.030 |
Why?
|
| Meningitis | 1 | 1996 | 217 | 0.030 |
Why?
|
| Swine | 1 | 2004 | 5907 | 0.030 |
Why?
|
| Protein Binding | 3 | 2012 | 9345 | 0.030 |
Why?
|
| Cadaver | 1 | 1999 | 1358 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 2018 | 876 | 0.030 |
Why?
|
| Reoperation | 3 | 2002 | 4300 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 3842 | 0.030 |
Why?
|
| Needles | 1 | 1996 | 450 | 0.030 |
Why?
|
| Antibodies, Neoplasm | 1 | 2015 | 280 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 15251 | 0.030 |
Why?
|
| Brain | 6 | 2020 | 27101 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2004 | 23972 | 0.030 |
Why?
|
| Gynecology | 1 | 1998 | 526 | 0.030 |
Why?
|
| Outpatients | 1 | 2020 | 1596 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2023 | 8618 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2008 | 3351 | 0.030 |
Why?
|
| Encephalitis, Japanese | 1 | 1992 | 13 | 0.030 |
Why?
|
| Cranial Nerve Diseases | 1 | 2013 | 111 | 0.030 |
Why?
|
| Tacrolimus | 1 | 2016 | 733 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2812 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 2948 | 0.020 |
Why?
|
| Headache | 1 | 2020 | 1255 | 0.020 |
Why?
|
| Length of Stay | 2 | 2007 | 6418 | 0.020 |
Why?
|
| Deafness | 1 | 1996 | 459 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1997 | 1663 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2000 | 2241 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2001 | 2331 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2012 | 337 | 0.020 |
Why?
|
| Collagen | 1 | 2000 | 2634 | 0.020 |
Why?
|
| ROC Curve | 1 | 1999 | 3575 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 2650 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 6403 | 0.020 |
Why?
|
| Age Distribution | 2 | 2007 | 2871 | 0.020 |
Why?
|
| Papilledema | 1 | 2013 | 130 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 1996 | 597 | 0.020 |
Why?
|
| Skull | 1 | 1996 | 818 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1981 | 2234 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2012 | 246 | 0.020 |
Why?
|
| Cricetulus | 1 | 2013 | 814 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 465 | 0.020 |
Why?
|
| Teaching | 1 | 1998 | 1169 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1879 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2023 | 3182 | 0.020 |
Why?
|
| Inhalation | 1 | 2011 | 143 | 0.020 |
Why?
|
| Infant, Newborn | 4 | 2017 | 26180 | 0.020 |
Why?
|
| Ambulances | 1 | 2011 | 91 | 0.020 |
Why?
|
| Graft Survival | 1 | 2001 | 3820 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6188 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1739 | 0.020 |
Why?
|
| CHO Cells | 1 | 2013 | 1387 | 0.020 |
Why?
|
| Gene Library | 1 | 2013 | 1055 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18221 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 451 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2003 | 2634 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1999 | 6338 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 9712 | 0.020 |
Why?
|
| Sacrococcygeal Region | 1 | 2009 | 53 | 0.020 |
Why?
|
| Femur | 1 | 1996 | 1307 | 0.020 |
Why?
|
| Urinary Bladder | 2 | 2009 | 1151 | 0.020 |
Why?
|
| Health Surveys | 2 | 2010 | 4037 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3877 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2013 | 878 | 0.020 |
Why?
|
| Inpatients | 1 | 2020 | 2544 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 1914 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1970 | 0.020 |
Why?
|
| Prognosis | 3 | 2016 | 29600 | 0.020 |
Why?
|
| Radiography | 1 | 2020 | 6961 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2012 | 2518 | 0.020 |
Why?
|
| Hemoglobins, Abnormal | 1 | 1989 | 118 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2022 | 5293 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5463 | 0.020 |
Why?
|
| Cervix Uteri | 1 | 2012 | 570 | 0.020 |
Why?
|
| Comorbidity | 2 | 2016 | 10505 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1483 | 0.020 |
Why?
|
| Hand | 1 | 2013 | 902 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 2533 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 2178 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 20074 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 933 | 0.020 |
Why?
|
| Coenzymes | 1 | 2007 | 102 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2007 | 219 | 0.020 |
Why?
|
| Polyethyleneimine | 1 | 2007 | 68 | 0.020 |
Why?
|
| Algorithms | 2 | 2010 | 14018 | 0.020 |
Why?
|
| Sirolimus | 1 | 2013 | 1533 | 0.020 |
Why?
|
| Epilepsies, Partial | 1 | 1990 | 431 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 2921 | 0.020 |
Why?
|
| NADP | 1 | 2007 | 227 | 0.020 |
Why?
|
| United States | 6 | 2011 | 72272 | 0.020 |
Why?
|
| Age Factors | 3 | 2007 | 18381 | 0.020 |
Why?
|
| Prevalence | 3 | 2008 | 15689 | 0.020 |
Why?
|
| Automobile Driving | 1 | 2011 | 441 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2011 | 704 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2013 | 1088 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1118 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 997 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 2456 | 0.020 |
Why?
|
| Quality of Life | 3 | 2003 | 13347 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2057 | 0.010 |
Why?
|
| Kinetics | 1 | 2012 | 6370 | 0.010 |
Why?
|
| Genetics, Population | 1 | 1989 | 935 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3879 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4269 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2011 | 1661 | 0.010 |
Why?
|
| NAD | 1 | 2007 | 614 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2017 | 5073 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2007 | 751 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12043 | 0.010 |
Why?
|
| Middle Cerebral Artery | 1 | 2004 | 274 | 0.010 |
Why?
|
| Sex Factors | 1 | 2016 | 10548 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4845 | 0.010 |
Why?
|
| Polypropylenes | 1 | 2002 | 62 | 0.010 |
Why?
|
| HIV Infections | 2 | 2020 | 17337 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22115 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1981 | 225 | 0.010 |
Why?
|
| Time Factors | 3 | 2016 | 39913 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2004 | 1370 | 0.010 |
Why?
|
| Retreatment | 1 | 2002 | 596 | 0.010 |
Why?
|
| Echocardiography | 1 | 2012 | 4987 | 0.010 |
Why?
|
| Pelvimetry | 1 | 1999 | 6 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2011 | 4470 | 0.010 |
Why?
|
| Risk Factors | 4 | 2010 | 74115 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13495 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9476 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1981 | 1376 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2009 | 8311 | 0.010 |
Why?
|
| Fascia | 1 | 1998 | 140 | 0.010 |
Why?
|
| Phenotype | 1 | 1996 | 16571 | 0.010 |
Why?
|
| Audiovisual Aids | 1 | 1998 | 99 | 0.010 |
Why?
|
| Urethra | 1 | 2000 | 403 | 0.010 |
Why?
|
| Cystoscopes | 1 | 1997 | 4 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2007 | 2595 | 0.010 |
Why?
|
| Data Collection | 1 | 2006 | 3315 | 0.010 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1999 | 361 | 0.010 |
Why?
|
| Dogs | 1 | 1981 | 3838 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12334 | 0.010 |
Why?
|
| Research Design | 1 | 2012 | 6174 | 0.010 |
Why?
|
| Parity | 1 | 1999 | 924 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 1999 | 503 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1999 | 773 | 0.010 |
Why?
|
| Medical Records | 1 | 1999 | 1407 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 12719 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11736 | 0.010 |
Why?
|
| Educational Measurement | 1 | 1998 | 1252 | 0.010 |
Why?
|
| Catheterization | 1 | 1997 | 1428 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1998 | 1528 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 1996 | 980 | 0.010 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1989 | 16 | 0.010 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1998 | 1068 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 26049 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 17878 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1997 | 9643 | 0.000 |
Why?
|
| Internship and Residency | 1 | 1998 | 5878 | 0.000 |
Why?
|